Xavier Armoiry, Hans-Martin Spath, Aileen Clarke, Martin Connock, Paul Sutcliffe, & Claude Dussart. (2019). Comparison of health technology assessment for new medicines in France and England: An example based on ixazomib for patients with relapsed or refractory multiple myeloma. Taylor & Francis Group.
Chicago Style (17th ed.) CitationXavier Armoiry, Hans-Martin Spath, Aileen Clarke, Martin Connock, Paul Sutcliffe, and Claude Dussart. Comparison of Health Technology Assessment for New Medicines in France and England: An Example Based on Ixazomib for Patients with Relapsed or Refractory Multiple Myeloma. Taylor & Francis Group, 2019.
MLA (9th ed.) CitationXavier Armoiry, et al. Comparison of Health Technology Assessment for New Medicines in France and England: An Example Based on Ixazomib for Patients with Relapsed or Refractory Multiple Myeloma. Taylor & Francis Group, 2019.